(Q36667556)

15 August 2017

Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer (English)

1 reference

15 August 2017

1 reference

Christine M Mueller

1

1 reference

15 August 2017

Phuong L Mai

2

1 reference

15 August 2017

Jaime Bucher

3

1 reference

15 August 2017

June A Peters

4

1 reference

15 August 2017

Jennifer T Loud

5

1 reference

15 August 2017

Mark H Greene

6

1 reference

15 August 2017

30 April 2008

1 reference

BMC Complementary and Alternative Medicine

15 August 2017

1 reference

15 August 2017

8

1 reference

15 August 2017

17

1 reference

Creative Commons Attribution 2.0 Generic

15 August 2017

start time

30 April 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1472-6882-8-17

0 references

cites work

Complementary and alternative medicine use among breast cancer survivors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Missing data on the Center for Epidemiologic Studies Depression Scale: a comparison of 4 imputation techniques

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Prevention and management of hereditary breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Complementary and alternative medicine use among adults: United States, 2002

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Safety issues in using complementary and alternative medicine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Use of alternative therapies for menopause symptoms: results of a population-based survey.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Prevalence and treatment of menopausal symptoms among breast cancer survivors

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Alternative therapies used by women with breast cancer in four ethnic populations

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Psychological side effects of breast cancer screening.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Complementary and alternative medicine use among American women: findings from The National Health Interview Survey, 2002.

28 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

Depression and the use of complementary medicine among breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6882-8-17

Complementary medicine use among women enrolled in a genetic testing program

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Use of complementary medicine by adult patients participating in cancer clinical trials.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2391138

Complementary Medicine Use before and 1 Year Following Genetic Testing for BRCA1/2 Mutations

20 September 2018

1 reference

12 December 2020

Behavioral risk factors among women presenting for genetic testing

1 reference

12 December 2020

Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing

1 reference

12 December 2020

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing

1 reference

12 December 2020

Attitudes about genetic testing for breast-ovarian cancer susceptibility

1 reference

12 December 2020

Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6882-8-17

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

1 reference